Avanafil: A Next-Generation PDE5 Inhibitor for Rapid and Reliable Erectile Dysfunction Treatment
Avanafil, with the CAS number 330784-47-9, is a highly selective phosphodiesterase type 5 (PDE5) inhibitor designed for the treatment of erectile dysfunction (ED). As a second-generation oral PDE5 inhibitor, Avanafil offers significant advantages in onset speed, target selectivity, and patient tolerability. Marketed globally under brand names such as Stendra and Spedra, Avanafil has become a…
Read article